Published in Vaccine on November 12, 2001
Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol (2009) 1.48
Whooping cough--a continuing problem. BMJ (2002) 1.43
Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol (2004) 1.35
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol (2005) 1.23
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol (2007) 1.14
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med (2009) 1.11
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
Vaccination and the dynamics of immune evasion. J R Soc Interface (2007) 1.06
Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05
Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis (2005) 1.00
Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J Clin Microbiol (2003) 0.98
SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One (2011) 0.93
Studies on Prn variation in the mouse model and comparison with epidemiological data. PLoS One (2011) 0.91
Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin. Infect Immun (2008) 0.89
Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol (2002) 0.89
Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol (2012) 0.86
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82
Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine (2011) 0.81
Pertussis. A reemerging and an underreported infectious disease. Saudi Med J (2014) 0.80
The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice. Infect Immun (2013) 0.77
Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function. PLoS One (2015) 0.76
What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature? N Am J Med Sci (2009) 0.75
Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran. Int J Mol Cell Med (2015) 0.75
Strategies and new developments to control pertussis, an actual health problem. Pathog Dis (2015) 0.75
Immunopathological aspects of hepatitis type B. Am J Med Sci (1977) 1.22
Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol (1980) 1.08
Autoimmune chronic active hepatitis developing after acute type B hepatitis. Dig Dis Sci (1989) 1.03
Linker histones play a role in male meiosis and the development of pollen grains in tobacco. Plant Cell (1999) 0.96
Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin Exp Immunol (1984) 0.95
Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol (1992) 0.95
Cellular localization of hepatitis B virus antigens in patients with hepatocellular carcinoma coexisting with liver cirrhosis. J Infect Dis (1977) 0.90
Diagnostic value of different serological tests for tuberculosis in Poland. J Physiol Pharmacol (2004) 0.86
Lack of hepatitis B virus DNA sequences in sera from patients with acute and chronic liver diseases diagnosed as non-A, non-B-hepatitis. Liver (1986) 0.84
Localization of hepatitis B virus antigens in hepatocellular carcinoma. Prog Med Virol (1981) 0.83
PCR for identification and typing of Helicobacter pylori isolated from children. J Physiol Pharmacol (1996) 0.82
Severe exacerbation of chronic active hepatitis B during interferon alpha therapy. Digestion (1992) 0.82
Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland. J Hepatol (1992) 0.81
The prevalence of anti-rubella antibodies in women of childbearing age in Poland. Vaccine (2004) 0.80
Hepatitis B virus and delta infection in male homosexuals. Liver (1986) 0.78
Introduction of hepatitis delta virus into Polish drug community. Infection (1992) 0.78
Technical aspects of random amplified polymorphic DNA (RAPD) technique in genotyping of bacterial strains. Acta Microbiol Pol (1999) 0.78
[Antibodies against Cytomegalovirus and Herpes simplex virus in alcoholics and drug addicts]. Przegl Epidemiol (1991) 0.77
Detection of enterotoxigenic Clostridium perfringens with a duplex PCR. J Med Microbiol (2002) 0.77
Molecular epidemiology survey of toxinogenic Clostridium perfringens strain types by multiplex PCR. Scand J Infect Dis (2000) 0.77
Kidney glomerular pathology in various forms of acute and chronic hepatitis. Arch Pathol Lab Med (1979) 0.77
Serum IgE levels in HIV-infected patients in Poland. Allergy (2000) 0.77
Etiopathogenetic aspects of hepatitis A II. Specific and nonspecific humoral immune response during the course of infection. J Med Virol (1984) 0.76
Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure. Am J Gastroenterol (1990) 0.76
Etiopathogenetic aspects of hepatitis A. I. Excretion of hepatitis A virus, biochemistry of liver function, and humoral immune response in patients with hepatitis A on admission to hospital. J Med Virol (1985) 0.75
Chronic active hepatitis in alcoholics. Am J Gastroenterol (1991) 0.75
[Hepatitis B virus infection in alcoholics]. Pol Tyg Lek (1992) 0.75
[Application of polymerase chain reaction (PCR) for the detection of DNA-HCMV in cerebrospinal fluid of neonates and infants with cytomegalovirus infection]. Neurol Neurochir Pol (1998) 0.75
[Etiopathogenesis and treatment of chronic autoimmune active hepatitis]. Pol Tyg Lek (1993) 0.75
[Liver damage in drug addicts]. Pol Tyg Lek (1993) 0.75
[Influence of therapy with glucocorticosteroids on clinical status, t4 lymphocyte count and t4/t8 lymphocyte ratio in people infected with AIDS]. Pol Arch Med Wewn (1991) 0.75
Cytomegalovirus infection presenting as hepatitis. Digestion (1990) 0.75
[Affinity of antibody anti-HBs in patients after asymptomatic or symptomatic infection with hepatitis B virus and in individuals vaccinated against this virus]. Pol Tyg Lek (1993) 0.75
[Alpha-fetoprotein and its appearance in primary liver carcinoma]. Pol Arch Med Wewn (1973) 0.75
[Application of DNA molecular hybridization for detection of hepatitis b virus in diagnosis of the infection]. Postepy Hig Med Dosw (1991) 0.75
[Corticosteroids in the treatment of chronic active hepatitis]. Pol Arch Med Wewn (1990) 0.75
[The effect of discontinuing intravenous opiate injections and methadone treatment on the status of the immune system in narcotic abusers with HIV]. Pol Tyg Lek (1996) 0.75
Interleukin 2 receptor positive T lymphocytes in renal allograft recipients: association with CMV infection. Mater Med Pol (1993) 0.75
[Human cytomegalovirus infection in the pre- and postnatal period with special regards to routes of infection]. Pediatr Pol (1996) 0.75
[Severe exacerbation of chronic hepatitis B following interferon therapy]. Wiad Lek (1992) 0.75
[Autoantibodies in Addison-Biermer disease]. Acta Haematol Pol (1974) 0.75
Affinity of anti-GP41 antibody in patients infected with human immunodeficiency virus type 1. Eur J Clin Invest (1993) 0.75
Letter: Hepatitis-B antigen and homologous antibodies in Burkitt's lymphoma and nasopharyngeal carcinoma. Lancet (1974) 0.75
[Beta-2 microglobulin as a non-specific marker of immunodeficiency in individuals infected with human immunodeficiency virus (HIV)]. Pol Arch Med Wewn (1991) 0.75
Course and outcome of acute type B hepatitis in heavy alcohol abusers. Digestion (1991) 0.75
Short-term corticosteroid therapy for chronic active hepatitis B. Digestion (1990) 0.75
[Occurrence of antibodies against hepatitis C virus (HCV) among alcoholics]. Pol Arch Med Wewn (1992) 0.75
[Superinfection with delta hepatitis virus--case report]. Pol Arch Med Wewn (1990) 0.75
Acute non-A, non-B hepatitis in a hospital population in Warsaw, Poland: clinical and epidemiological aspects. Am J Gastroenterol (1991) 0.75
[Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts]. Pol Arch Med Wewn (1992) 0.75
[Delta virus infection among drug addicts]. Pol Arch Med Wewn (1991) 0.75
[Autoantibodies in children with pneumocystis carinii pneumonia]. Pediatr Pol (1976) 0.75
[Appearance of thrombocytopenia in patients infected with HIV]. Pol Tyg Lek (1993) 0.75
[Use of electrophoresis in polyacrylomide gel (SDS_PAGE) for evaluating IgG structure--the main component of human intravenous immunoglobulin]. Med Dosw Mikrobiol (2000) 0.75
Letter: Smooth muscle antibody in children with Pneumocystis carinii pneumonia. J Pediatr (1975) 0.75
[Appearance of antibodies against hepatitis type A virus (HAV) in alcoholics]. Wiad Lek (1992) 0.75
[Chlamydial infections in man]. Pol Arch Med Wewn (1991) 0.75
[Cytomegalovirus hepatitis]. Pol Arch Med Wewn (1991) 0.75
[Occurrence of autoimmune phenomena in persons infected with HIV. II. Clinical manifestations]. Wiad Lek (1993) 0.75
[Hepatitis A in drug addicts]. Wiad Lek (1992) 0.75
Liver disease among Polish alcoholics. Contribution of chronic active hepatitis to liver pathology. Liver (1990) 0.75
[Hepatitis B among drug addicts]. Pol Tyg Lek (1992) 0.75
Immunoglobulin content of experimentally induced amyloid in hamsters. Arch Immunol Ther Exp (Warsz) (1979) 0.75
[Coexpression of CD4 and CD8 antigens and the appearance of HLA-DR and CD25 receptors on lymphocytes as markers of immune activation in patients with HIV infection]. Pol Merkur Lekarski (1996) 0.75
[Non-A, non-B hepatitis--epidemiologic and clinical aspects]. Pol Arch Med Wewn (1991) 0.75
A follow-up study of an outbreak of non-A, non-B hepatitis in a plasmapheresis unit. Liver (1990) 0.75
[Susceptibility to vibriostatic factor 0/129 of Shigella, Salmonella and entero-invasive Escherichia coli (EIEC)]. Med Dosw Mikrobiol (1994) 0.75
[Chronic hepatitis B exacerbation following a short prednisone therapy resulting in death]. Pol Tyg Lek (1993) 0.75
Hepatitis C virus antibody in Poland. Scand J Infect Dis (1991) 0.75
[Titer of anti-P24 and anti-GP41 antibodies as a diagnostic parameter in patients with asymptomatic and symptomatic HIV infections]. Pol Arch Med Wewn (1991) 0.75
Affinity of anti-HBs antibody after hepatitis B vaccination. Eur J Clin Invest (1992) 0.75
Affinity and concentration of anti-HIV antibodies in asymptomatic and symptomatic HIV infection. Mater Med Pol (1992) 0.75
[Occurrence of autoimmune phenomena in persons infected with HIV.I. Pathogenetic aspects]. Wiad Lek (1993) 0.75
[Development of autoimmune chronic active hepatitis after acute hepatitis B]. Pol Tyg Lek (1990) 0.75
[Liver damage in alcoholics]. Postepy Hig Med Dosw (1991) 0.75
Clinical and immunological studies on healthy blood donors hepatitis B antibody carriers. Vox Sang (1977) 0.75
[Serological markers of hepatitis b and hepatitis d among individuals with symptomatic and asymptomatic HIV infection]. Pol Arch Med Wewn (1991) 0.75
[T4 lymphocytes (helper cells) and T8 lymphocytes (cytotoxic and suppressor cells) in patients with asymptomatic and symptomatic HIV infection]. Pol Arch Med Wewn (1991) 0.75
[A strain of Aeromonas veronii isolated from a patient suspected of cholera]. Med Dosw Mikrobiol (1992) 0.75
[Retroviruses in human pathology]. Pol Arch Med Wewn (1991) 0.75
Affinity of anti-HIV antibodies in patients with asymptomatic and symptomatic HIV infection. Przegl Epidemiol (1991) 0.75
[Procollagen type III peptides in chronic viral hepatitis]. Pol Tyg Lek (1993) 0.75
[Evaluation of humoral immune response in patients with asymptomatic and symptomatic HIV infection. Analysis of titers of anti-Hbs, antibodies against cytomegalovirus, herpes simplex virus type I, rubella virus and toxoplasma gondii]. Pol Arch Med Wewn (1993) 0.75
[Efficacy of hepatitis B vaccine after intramuscular or intradermal administration]. Pol Arch Med Wewn (1993) 0.75
[Occurrence of alpha-fetoprotein in various forms of hepatitis, cirrhosis and primary hepatic cancer]. Pol Arch Med Wewn (1973) 0.75
[Renovascular complications of hepatitis B]. Bull Acad Natl Med (1980) 0.75
[Prospective studies of T4 and T8 lymphocyte subpopulations and beta 2-microglobulin in patients with HIV infection]. Pol Arch Med Wewn (1991) 0.75
[Epidemic focus of non-A, non-B viral hepatitis in a plasmapheresis unit]. Pol Tyg Lek (1992) 0.75
[Hepatitis A. Progress in the diagnostic and epidemiological studies]. Przegl Epidemiol (1979) 0.75
[Long-term asymptomatic HIV infection--pathogenetic aspects]. Pol Arch Med Wewn (1995) 0.75
[Occurrence of free receptor for interleukin 2 in serum and quantitative determinations of CD25+ in patients infected with HIV]. Pol Arch Med Wewn (1994) 0.75
[Occurrence of HIV antigens in patients with acquired immunodeficiency syndrome]. Pol Arch Med Wewn (1991) 0.75
[Quantitative assay of CD8+ (cytotoxic and suppressor) lymphocytes in patients with both asymptomatic and symptomatic HIV infection]. Pol Tyg Lek (1993) 0.75
[Antibody avidity in diagnosis of toxoplasmosis]. Pol Tyg Lek (1996) 0.75
[Markers of HBV infection in drug addicts]. Pol Arch Med Wewn (1992) 0.75
[Presence of autoantibodies in patients infected with HIV]. Pol Merkur Lekarski (1996) 0.75
Genotypes of Helicobacter pylori in Polish population. Acta Microbiol Pol (1999) 0.75
[Occurrence of autoimmune phenomena in persons infected with HIV. III. Laboratory diagnosis]. Wiad Lek (1993) 0.75
[Markers of hepatitis A infection in drug addicts]. Pol Tyg Lek (1993) 0.75
[Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection]. Pol Tyg Lek (1993) 0.75